(20 mg + 50 mg)/g, ointment
Allantoin + Dexpanthenol
You should carefully read the contents of the leaflet before using the medicine, as it contains
important information for the patient.
This medicine should always be used exactly as described in this patient leaflet or as directed by
your doctor or pharmacist.
Alantan Plus is a topical ointment for application to the skin.
The medicine contains two active substances: allantoin and dexpanthenol. Allantoin has a keratolytic and protective effect on the skin, improves its hydration, and supports wound healing by stimulating the growth of new tissue. Regular use of allantoin in hyperkeratotic skin conditions can prevent excessive keratin deposition (a type of protein).
Dexpanthenol penetrates deep into the skin, where it is converted into pantothenic acid. Increased demand for pantothenic acid occurs in the case of skin damage and various skin diseases. Dexpanthenol has the ability to bind water, which increases skin elasticity.
If any signs of hypersensitivity (such as redness, burning sensation) occur at the site of application, the use of the medicine should be discontinued and a doctor or pharmacist consulted.
The patient should inform their doctor or pharmacist about all medicines they are currently taking or have recently taken, as well as any medicines they plan to take.
No interactions have been found between Alantan Plus and other medicines used topically on the skin.
If the patient is pregnant or breastfeeding, thinks they may be pregnant, or plans to have a child, they should consult their doctor or pharmacist before using this medicine.
There is no data on the safety of using the medicine in pregnant and breastfeeding women.
No effect of the medicine on the ability to drive and use machines, as well as on psychophysical fitness, has been found.
This medicine should always be used exactly as described in this patient leaflet or as directed by the doctor or pharmacist.
In case of doubt, the patient should consult their doctor or pharmacist.
The medicine is intended for topical use on the skin.
Affected areas should be smeared, unless the doctor recommends otherwise, usually once or several times a day.
Care of infants:
apply to areas prone to diaper rash (after each diaper change). Before applying the ointment, the skin should be washed and dried.
If there is no improvement or the patient feels worse, they should contact their doctor.
There is no data on overdose when using the medicine as described in the leaflet.
In case of accidental ingestion, the patient should consult their doctor.
The patient should not use a double dose to make up for a missed dose.
In case of any further doubts related to the use of this medicine, the patient should consult their doctor or pharmacist.
Like all medicines, this medicine can cause side effects, although not everybody gets them.
Hypersensitivity reactions, skin irritation (see also section 2: Important information before using Alantan Plus - Warnings and precautions) may occur.
If any undesirable effects occur, including any undesirable effects not listed in this leaflet, the patient should inform their doctor or pharmacist or nurse.
Side effects can be reported directly to the Department of Post-Marketing Surveillance of the Office for Registration of Medicinal Products, Medical Devices, and Biocidal Products
Al. Jerozolimskie 181C, 02-222 Warsaw
tel.: +48 22 49 21 301, fax: +48 22 49 21 309
website: https://smz.ezdrowie.gov.pl
Side effects can also be reported to the marketing authorization holder.
Reporting side effects helps to gather more information on the safety of the medicine.
The medicine should be stored out of sight and reach of children.
Store in a temperature below 25°C, in the original packaging.
Do not use this medicine after the expiry date stated on the packaging.
The expiry date refers to the last day of the given month.
Shelf life after first opening the packaging – 6 months.
Alantan Plus can be used for 6 months from the date of first use, without exceeding the expiry date stated on the packaging.
In this window, the date of first use of the medicine should be entered:
Medicines should not be disposed of via wastewater or household waste containers. The patient should ask their pharmacist how to dispose of medicines that are no longer needed. This will help protect the environment.
Alantan Plus is a yellow-colored ointment with a uniform consistency.
Packaging:
An internally lacquered aluminum tube with a membrane and a PE cap, containing 30 g or 100 g of ointment, placed in a cardboard box with a patient leaflet.
Zakłady Farmaceutyczne „UNIA” Spółdzielnia Pracy
ul. Chłodna 56/60
00-872 Warsaw
tel.: 22 620 90 81 ext. 190
fax: 22 654 92 40
e-mail: unia@uniapharm.pl
The content of the Alantan Plus leaflet is available in the Ulotka Audio system under the nationwide, free phone number: 800 706 848.
Need help understanding this medicine or your symptoms? Online doctors can answer your questions and offer guidance.